Mimedx (MDXG) Tax Provisions (2013 - 2026)
Mimedx recorded quarterly Tax Provisions of -$4.5 million in Q1 2026, down 167.7% quarter-over-quarter from $6.6 million in Q4 2025, and down 381.37% year-over-year from $1.6 million in Q1 2025.
Mimedx's Tax Provisions history runs 14 years deep, the most recent figure standing at -$4.5 million for Q1 2026.
- In Q1 2026, Tax Provisions fell 381.37% year-over-year to -$4.5 million; the TTM figure through Mar 2026 stood at $11.6 million (down 20.04% YoY), while the FY2025 annual figure was $17.7 million, up 15.61% from the prior year.
- Tax Provisions came in at -$4.5 million for Q1 2026 at Mimedx, down from $6.6 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $6.6 million in Q4 2025 to a low of -$37.4 million in Q4 2023.
- A 5-year average of -$476117.6 and a median of $591000.0 in 2023 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions plunged 133582.14% in 2023 and surged 7660.81% in 2024, its largest moves.
- Mimedx's Tax Provisions stood at $28000.0 in 2022, then slumped by 133582.14% to -$37.4 million in 2023, then jumped by 110.2% to $3.8 million in 2024, then jumped by 73.29% to $6.6 million in 2025, then tumbled by 167.7% to -$4.5 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered -$4.5 million, $6.6 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -4.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.47 Mn |
| Dec 31, 2025 | 6.60 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Jun 30, 2025 | 3.39 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | 3.54 Mn |
| Jun 30, 2024 | 5.60 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Dec 31, 2023 | -37.38 Mn |
| Sep 30, 2023 | 591,000.00 |
| Jun 30, 2023 | -74,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Sep 30, 2022 | 53,000.00 |
| Jun 30, 2022 | 62,000.00 |
| Mar 31, 2022 | 63,000.00 |
| Dec 31, 2021 | -108,000.00 |
| Sep 30, 2021 | 301,000.00 |
| Jun 30, 2021 | -5,000.00 |
| Mar 31, 2021 | 58,000.00 |
| Dec 31, 2020 | -1.02 Mn |
| Sep 30, 2020 | 38,000.00 |
| Jun 30, 2020 | 27,000.00 |
| Mar 31, 2020 | -11.30 Mn |
| Dec 31, 2019 | 220,000.00 |
| Sep 30, 2019 | -309,000.00 |
| Jun 30, 2019 | 42,000.00 |
| Mar 31, 2019 | 42,000.00 |
| Dec 31, 2018 | 27.50 Mn |
| Sep 30, 2018 | 650,000.00 |
| Jun 30, 2018 | -13,000.00 |
| Mar 31, 2018 | -1.55 Mn |
| Dec 31, 2017 | 9.54 Mn |
| Sep 30, 2017 | -500,000.00 |
| Jun 30, 2017 | 980,000.00 |
| Mar 31, 2017 | 280,000.00 |
| Dec 31, 2016 | -2.83 Mn |
| Sep 30, 2016 | 1.30 Mn |
| Jun 30, 2016 | 1.48 Mn |
| Mar 31, 2016 | 214,000.00 |
| Dec 31, 2015 | -5.70 Mn |
| Sep 30, 2015 | 158,000.00 |
| Jun 30, 2015 | 223,000.00 |
| Mar 31, 2015 | 146,000.00 |
| Dec 31, 2014 | 810,000.00 |
| Sep 30, 2014 | 22,000.00 |
| Jun 30, 2014 | -10,000.00 |
| Mar 31, 2014 | 10,000.00 |
| Dec 31, 2013 | 3,025.00 |
| Sep 30, 2013 | 46,700.00 |
| Mar 31, 2013 | 50,275.00 |